WO2005034954A3 - Pharmaceutical compositions of paroxetine containing microcrystalline cellulose, prepared by wet granulation - Google Patents
Pharmaceutical compositions of paroxetine containing microcrystalline cellulose, prepared by wet granulation Download PDFInfo
- Publication number
- WO2005034954A3 WO2005034954A3 PCT/IB2004/003295 IB2004003295W WO2005034954A3 WO 2005034954 A3 WO2005034954 A3 WO 2005034954A3 IB 2004003295 W IB2004003295 W IB 2004003295W WO 2005034954 A3 WO2005034954 A3 WO 2005034954A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- prepared
- microcrystalline cellulose
- pharmaceutical compositions
- wet granulation
- paroxetine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04769597A EP1675574A2 (en) | 2003-10-08 | 2004-10-08 | Pharmaceutical compositions of paroxetine containing microcrystalline cellulose, prepared by wet granulation |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1247DE2003 | 2003-10-08 | ||
IN1247/DEL/2003 | 2003-10-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005034954A2 WO2005034954A2 (en) | 2005-04-21 |
WO2005034954A3 true WO2005034954A3 (en) | 2005-06-02 |
Family
ID=34430679
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2004/003295 WO2005034954A2 (en) | 2003-10-08 | 2004-10-08 | Pharmaceutical compositions of paroxetine containing microcrystalline cellulose, prepared by wet granulation |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP1675574A2 (en) |
WO (1) | WO2005034954A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007012968A2 (en) * | 2005-07-29 | 2007-02-01 | Aurobindo Pharma Ltd | Stable dosage form of an antidepressant |
CA2620108A1 (en) * | 2005-08-26 | 2007-03-01 | Bpsi Holdings Llc | Drug compositions containing controlled release hypromellose matrices |
US20090130206A1 (en) * | 2006-05-09 | 2009-05-21 | Umesh Nandkumar Khatavkar | Controlled Release Compositions of an Antidepressant Agent |
CN102525966B (en) * | 2010-12-13 | 2016-06-29 | 江苏万全特创医药生物技术有限公司 | A kind of tablet containing paroxetine and preparation method thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002055062A2 (en) * | 2001-01-11 | 2002-07-18 | Synthon B.V. | Pharmaceutical tablet comprising paroxetine mesylate |
WO2002069969A1 (en) * | 2001-03-02 | 2002-09-12 | A/S Gea Farmaceutisk Fabrik | A process for the manufacture of pharmaceutical tablets containing paroxetine hydrochloride anhydrate |
WO2003057150A2 (en) * | 2001-12-28 | 2003-07-17 | Teva Pharmaceutical Industries Ltd. | A stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof |
WO2004058229A1 (en) * | 2002-12-24 | 2004-07-15 | Biovail Laboratories Inc. | Modified release formulations of selective serotonin re-uptake inhibitors |
-
2004
- 2004-10-08 EP EP04769597A patent/EP1675574A2/en not_active Withdrawn
- 2004-10-08 WO PCT/IB2004/003295 patent/WO2005034954A2/en not_active Application Discontinuation
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002055062A2 (en) * | 2001-01-11 | 2002-07-18 | Synthon B.V. | Pharmaceutical tablet comprising paroxetine mesylate |
WO2002069969A1 (en) * | 2001-03-02 | 2002-09-12 | A/S Gea Farmaceutisk Fabrik | A process for the manufacture of pharmaceutical tablets containing paroxetine hydrochloride anhydrate |
WO2003057150A2 (en) * | 2001-12-28 | 2003-07-17 | Teva Pharmaceutical Industries Ltd. | A stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof |
WO2003057151A2 (en) * | 2001-12-28 | 2003-07-17 | Teva Pharmaceutical Industries Ltd. | A stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof |
WO2004058229A1 (en) * | 2002-12-24 | 2004-07-15 | Biovail Laboratories Inc. | Modified release formulations of selective serotonin re-uptake inhibitors |
Also Published As
Publication number | Publication date |
---|---|
WO2005034954A2 (en) | 2005-04-21 |
EP1675574A2 (en) | 2006-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004062577A3 (en) | Two or more enteric materials to regulate drug release | |
WO2001032632A3 (en) | Pharmaceutically active 4-substituted pyrimidine derivatives | |
AU2003244632A1 (en) | Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them | |
WO2005069933A3 (en) | Methods of treating an inflammatory-related disease | |
WO2006138735A3 (en) | Gel compositions for topical administration | |
AU2003227741A1 (en) | Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them | |
WO2006024486A3 (en) | Amide derivatives of 3-phenyl dihydropyrimido[4,5-d]pyrimidinones, their manufacture and use as pharmaceutical agents | |
WO2007052289A3 (en) | Novel dispersible tablet composition | |
IL139227A0 (en) | N-substituted aminotetralins as ligands for the neuropeptide yy5 receptor useful in the treatment of obesity and other disorders | |
AU2003270255A1 (en) | Fast releasing, solid administration form for oral application of active ingredients which are hard to dissolve | |
WO2007090882A3 (en) | Pharmaceutical extended release compositions comprising pramipexole | |
AU2003244649A1 (en) | Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them | |
HK1067626A1 (en) | Novel 2h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient | |
NO20043367L (en) | Oral pharmaceutical preparation | |
NO20050018L (en) | Lasofoxifene tablets and coatings | |
WO2004078105A3 (en) | Fondaparinux sodium composition of high purity, method for production of said composition and pharmaceutical compositions containing the same as active ingredient | |
WO2006042954A8 (en) | 2-amido-4-phenylthiazole derivatives, the preparation and the therapeutic use thereof | |
WO2001095856A3 (en) | Urea derivative useful as an anti-cancer agent and process for preparing same | |
WO2003014079A8 (en) | Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments | |
WO2003057150A3 (en) | A stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof | |
AU2363902A (en) | Crystalline forms of fluvastatin sodium | |
WO2006097943A3 (en) | Pharmaceutical compositions of amlodipine and benazepril | |
WO2003026610A3 (en) | Process for the preparation of fast dissolving dosage form | |
RS11304A (en) | Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation | |
FR2819720B1 (en) | NEW FENOFIBRATE TABLETS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2004769597 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2448/DELNP/2006 Country of ref document: IN |
|
WWP | Wipo information: published in national office |
Ref document number: 2004769597 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2004769597 Country of ref document: EP |